cardiovascular disease

Health Megan Molteni

Genetically altered pig heart transplanted into a human for the second time

Biotech Damian Garde

STAT Plus: FDA panel endorses Alnylam’s heart drug — after picking apart its supporting data

Health Deborah Balthazar

Obesity-related cardiovascular deaths tripled in the last two decades, new study finds

The Obesity Revolution Simar Bajaj

STAT Plus: What do new weight loss drugs mean for the future of bariatric surgery?

Health Elaine Chen

STAT Plus: Weight loss drug Wegovy improves function in people with common type of heart failure

Health tech Lizzy Lawrence

STAT Plus: FDA panel votes against high blood pressure device from Medtronic, but lends support to ReCor Medical’s

First Opinion Devabhaktuni Srikrishna

Home blood pressure machines are often wrong. The FDA must speak up

Biotech Matthew Herper

STAT Plus: Roche’s $3 billion Alnylam deal shows drug firms are interested in long-acting heart drugs

In the Lab Deborah Balthazar

Statins reduce cardiovascular risk in people living with HIV, new global study finds

Pharmalot Ed Silverman

STAT Plus: Novartis is scolded by U.K. trade group for the third time this year over Entresto marketing

Biotech Matthew Herper

STAT Plus: BridgeBio heart drug succeeds in pivotal study

Health Ambar Castillo

Living in a historically redlined area linked to worse heart health, study finds

Health Matthew Herper

Testosterone supplementation not linked to heart attacks in study, reversing earlier finding

Health Elaine Chen

STAT Plus: Transplant patients say new Medicare guidance puts their donated organs at risk

Health Elaine Chen

Reanimated hearts donated after death work just as well for transplants, study finds

Health Elaine Chen

STAT Plus: Insurance alone didn’t guarantee adherence to Ozempic, study finds

First Opinion Suhas Gondi

More young people should be getting their cholesterol tested and taking statins

Pharma Elaine Chen

STAT Plus: In early trial, drug appears to reduce harmful protein buildup in heart

Biotech Megan Molteni

STAT Plus: In its first tough test, CRISPR epigenome editing cuts cholesterol levels in monkeys

Health Elaine Chen

Oft-prescribed beta blockers may not be wise for many heart patients

Health Elaine Chen

Report on medical access finds one-third of Black Americans live in ‘cardiology deserts’

Lauran Neergaard — Associated Press

Putting radiation to the test to heal irregular heartbeat

In the Lab Jason Mast

Scientists, going on a bear hunt, find a potential way to treat deadly blood clots

Health tech Lizzy Lawrence

STAT Plus: Wireless pacemakers may work for children with slow heart rhythms — but first, doctors need child-sized catheters

The Readout LOUD Damian Garde, Meg Tirrell, and Adam Feuerstein

Listen: Robert Califf on how drugs get approved, plus the nascent revolution in obesity

Biotech Matthew Herper

STAT Plus: With a potent new medicine, Merck marks a return to cardiology

Pharma Matthew Herper

STAT Plus: After its drug was shown to prevent heart attacks, what’s next for Esperion?

Health Damian Garde and Matthew Herper

STAT Plus: Heart repair, risky genes, and AI: the buzz from a giant cardiovascular conference

Pharma Matthew Herper

STAT Plus: Esperion Therapeutics’ statin alternative reduces heart attack risk. Is that enough to save the company?